| -1.72 / -1.32%|
Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ.
|Paul M. Bisaro||President, Chief Executive Officer & Director|
|R. Todd Joyce, CPA||Global Chief Financial Officer|
|Charles D. Ebert, PhD||Senior Vice President-Research & Development|
|Thomas R. Giordano||Chief Information Officer & Senior Vice President|
|Patrick G. Brunner||Senior VP-Global Manufacturing Operations|